Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 3
2011 1
2012 4
2013 9
2014 2
2016 2
2017 1
2019 2
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Oral candidosis in relation to oral immunity.
Feller L, Khammissa RA, Chandran R, Altini M, Lemmer J. Feller L, et al. J Oral Pathol Med. 2014 Sep;43(8):563-9. doi: 10.1111/jop.12120. Epub 2013 Oct 9. J Oral Pathol Med. 2014. PMID: 24118267 Review.
Some immune cells including NKT cells, gammadelta T cells and lymphoid cells that are innate to the oral mucosa have the capacity to produce large quantities of IL-17 in response to C. albicans, sufficient to mediate effective protective immunity against C. albicans …
Some immune cells including NKT cells, gammadelta T cells and lymphoid cells that are innate to the oral mucosa have the capacity to produce …
Performance and limitations of a supervised deep learning approach for the histopathological Oxford Classification of glomeruli with IgA nephropathy.
Altini N, Rossini M, Turkevi-Nagy S, Pesce F, Pontrelli P, Prencipe B, Berloco F, Seshan S, Gibier JB, Pedraza Dorado A, Bueno G, Peruzzi L, Rossi M, Eccher A, Li F, Koumpis A, Beyan O, Barratt J, Vo HQ, Mohan C, Nguyen HV, Cicalese PA, Ernst A, Gesualdo L, Bevilacqua V, Becker JU. Altini N, et al. Comput Methods Programs Biomed. 2023 Dec;242:107814. doi: 10.1016/j.cmpb.2023.107814. Epub 2023 Sep 13. Comput Methods Programs Biomed. 2023. PMID: 37722311 Free article.
The aim of our study was to replicate the glomerular components of Oxford scoring with an end-to-end deep learning pipeline that involves automatic glomerular segmentation followed by classification for mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental …
The aim of our study was to replicate the glomerular components of Oxford scoring with an end-to-end deep learning pipeline that involves au …
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study.
Foschi FG, Conti F, Domenicali M, Giacomoni P, Borghi A, Bevilacqua V, Napoli L, Berardinelli D, Altini M, Cucchetti A, Ercolani G, Casadei-Gardini A, Bellentani S, Gastaldelli A, Tiribelli C, Bedogni G, Group BS. Foschi FG, et al. J Clin Med. 2021 Feb 1;10(3):520. doi: 10.3390/jcm10030520. J Clin Med. 2021. PMID: 33535679 Free PMC article.
Calibration was evaluated by calculating the calibration slope and intercept and by inspecting calibration plots; discrimination was evaluated using the c-statistic. The average calibration slope was 1 and the average intercept was 0 for all combinations of outcomes and in …
Calibration was evaluated by calculating the calibration slope and intercept and by inspecting calibration plots; discrimination was evaluat …
Predictive Machine Learning Models and Survival Analysis for COVID-19 Prognosis Based on Hematochemical Parameters.
Altini N, Brunetti A, Mazzoleni S, Moncelli F, Zagaria I, Prencipe B, Lorusso E, Buonamico E, Carpagnano GE, Bavaro DF, Poliseno M, Saracino A, Schirinzi A, Laterza R, Di Serio F, D'Introno A, Pesce F, Bevilacqua V. Altini N, et al. Sensors (Basel). 2021 Dec 20;21(24):8503. doi: 10.3390/s21248503. Sensors (Basel). 2021. PMID: 34960595 Free PMC article.
From the survival analysis, it emerged that the most significant laboratory parameters for both outcomes was C-reactive protein min; HR=17.963 (95% CI 6.548-49.277, p < 0.001) for death, HR=1.789 (95% CI 1.000-3.200, p = 0.050) for admission to ICU. ...
From the survival analysis, it emerged that the most significant laboratory parameters for both outcomes was C-reactive protein min; …
[The Italian instrument evaluating the nursing students clinical learning quality].
Palese A, Grassetti L, Mansutti I, Destrebecq A, Terzoni S, Altini P, Bevilacqua A, Brugnolli A, Benaglio C, Dal Ponte A, De Biasio L, Dimonte V, Gambacorti B, Fasci A, Grosso S, Mantovan F, Marognolli O, Montalti S, Nicotera R, Randon G, Stampfl B, Tollini M, Canzan F, Saiani L, Zannini L. Palese A, et al. Assist Inferm Ric. 2017 Jan-Mar;36(1):41-50. doi: 10.1702/2676.27420. Assist Inferm Ric. 2017. PMID: 28398391 Italian.
The tool developed based upon a) literature, b) validated tools already established among other healthcare professionals, and c) consensus expressed by experts and nursing students, was administered to the eligible students. ...According to the findings, the tool consists …
The tool developed based upon a) literature, b) validated tools already established among other healthcare professionals, and c) cons …
Impact of pre-treatment variables on the completion of 223radium-dichloride therapy in mCRPC patients with bone metastases.
Lavelli V, Nappi AG, Caputo P, Asabella AN, Fanelli M, Sardaro A, Altini C, Ferrari C, Rubini G. Lavelli V, et al. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:153-163. Hell J Nucl Med. 2019. PMID: 31802056 Free article.
The population was grouped as patients who completed (223)Ra-therapy (group Ra223-C) and patients who do not (group (223)Ra-U). For each group, we analyzed the effects of potential pre-treatment variables (age, Gleason Score, tumor burden, "Time From Diagnosis To (223)Ra t …
The population was grouped as patients who completed (223)Ra-therapy (group Ra223-C) and patients who do not (group (223)Ra-U). For e …
[Validation of the Italian Clinical Learning Environment Instrument (SVIAT):<BR>study protocol].
Palese A, Destrebecq A, Terzoni S, Grassetti L, Altini P, Bevilacqua A, Brugnolli A, Benaglio C, Dalponte A, De Biasio L, Dimonte V, Gambacorti B, Fasci A, Grosso S, Mansutti I, Mantovan F, Marognolli O, Montalti S, Nicotera R, Perli S, Randon G, Stampfl B, Tollini M, Canzan F, Zannini L, Saiani L. Palese A, et al. Assist Inferm Ric. 2016 Jan-Mar;35(1):29-35. doi: 10.1702/2228.24018. Assist Inferm Ric. 2016. PMID: 27183424 Italian.
METHODS: The study will be developed in three phases: a) instrument development and pilot phase, b) validation of the psychometric properties of the instrument and c) description of the CLEs as perceived by the students including factors/item confirmed in the validation pr …
METHODS: The study will be developed in three phases: a) instrument development and pilot phase, b) validation of the psychometric propertie …
An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia.
Cerchione C, Martinelli G, Pedatella S, De Nisco M, Pugliese N, Manfra M, Marra N, Ronconi S, De Giorgi U, Altini M, Simonetti G, Di Rorà AGL, Bravaccini S, Catalano L, Dora Iula V, Pagano F, Picardi M, Bolognese A, Pane F, Martinelli V. Cerchione C, et al. Anticancer Drugs. 2020 Jan;31(1):67-72. doi: 10.1097/CAD.0000000000000850. Anticancer Drugs. 2020. PMID: 31633499 Free PMC article.
Cytarabine, the 4-amino-1-(beta-D-arabinofuranosyl)-2(1H)-pyrimidinone, (ARA-C) is an antimetabolite cytidine analogue used worldwide as key drug in the management of leukaemia. ...
Cytarabine, the 4-amino-1-(beta-D-arabinofuranosyl)-2(1H)-pyrimidinone, (ARA-C) is an antimetabolite cytidine analogue used worldwide …
29 results